Literature DB >> 31161617

Implications of exosomes as diagnostic and therapeutic strategies in cancer.

Ali Aghebati-Maleki1,2, Sanam Nami3, Amir Baghbanzadeh1, Bita H Karzar2, Saeed Noorolyai1, Ali Fotouhi4, Leili Aghebati-Maleki1,5.   

Abstract

Exosomes offer a new perspective on the biology of cancer with both diagnostic and therapeutic concepts. Due to the cell-to-cell association, exosomes are involved in the progression, metastasis, and therapeutic efficacy of the tumor. They can be isolated from blood and other body fluids to determine the disease progression in the body, including cancer growth. In addition to being reservoirs of biochemical markers of cancer, exomes can be designed to restore tumor immunity. Tumor exosomes interact with different cells in the tumor microenvironment to confer beneficial modulations, responsible for stromal activity, angiogenesis, increased vascular permeability, and immune evasion. Exosomes also contribute to the metastasis with the aim of epithelial transmission to the mesenchyme and the formation of premetastatic niches. Moreover, exosomes protect cells against the cytotoxic effects of chemotherapeutic drugs and prevent the transmission of chemotherapy resistance to adjacent cells. Therefore, exosomes are essential for many fatal cancer agents, and understanding their origins and role in cancer is important. In this article, we attempted to clarify the potential of exosomes for the application in cancer diagnosis and therapy.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  biochemical markers; cancer; diagnosis; exosomes

Mesh:

Substances:

Year:  2019        PMID: 31161617     DOI: 10.1002/jcp.28875

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

Review 1.  Liquid biopsies in myeloid malignancies.

Authors:  Bilal Abdulmawjood; Catarina Roma-Rodrigues; Alexandra R Fernandes; Pedro V Baptista
Journal:  Cancer Drug Resist       Date:  2019-12-19

Review 2.  microRNA and exosome profiling in multiple sclerosis.

Authors:  Marcin P Mycko; Sergio E Baranzini
Journal:  Mult Scler       Date:  2020-01-22       Impact factor: 6.312

3.  Plasma-Derived Exosomal ALIX as a Novel Biomarker for Diagnosis and Classification of Pancreatic Cancer.

Authors:  Jie Yang; Yixuan Zhang; Xin Gao; Yue Yuan; Jing Zhao; Siqi Zhou; Hui Wang; Lei Wang; Guifang Xu; Xihan Li; Pin Wang; Xiaoping Zou; Dongming Zhu; Ying Lv; Shu Zhang
Journal:  Front Oncol       Date:  2021-05-05       Impact factor: 6.244

Review 4.  Prognostic significance and therapeutic potentials of immune checkpoints in osteosarcoma.

Authors:  Vafa Meftahpour; Ali Aghebati-Maleki; Ali Fotouhi; Elham Safarzadeh; Leili Aghebati-Maleki
Journal:  EXCLI J       Date:  2022-01-12       Impact factor: 4.068

Review 5.  Exosomes in Bone Sarcomas: Key Players in Metastasis.

Authors:  Mariona Chicón-Bosch; Oscar M Tirado
Journal:  Cells       Date:  2020-01-17       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.